Form 4: Pacific Biosciences CEO Sells Shares to Cover Tax Obligations

Pacific Biosciences CEO Christian O. Henry sold 12,497 shares of common stock on March 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 3, 2025, Christian O. Henry, the President, CEO & Interim CFO of Pacific Biosciences of California, Inc., sold 12,497 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price ranging from $1.39 to $1.46 per share.
• Following the transaction, Henry directly owns 2,225,357 shares of Pacific Biosciences common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by an insider, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale appears to be a standard transaction to cover tax obligations.

Stakeholder Impact

• The sale of shares by an insider could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.

Key Dates